This is Why Investors are Pushing Into Psychedelics

Psychedelics have gone mainstream. For one researchers at New York University found psilocybin mushrooms caused a “rapid and sustained” reduction in anxiety and depression in patients with cancer, as reported by the Financial Post.  Two, there’s rapidly changing consumer attitudes towards psychedelics, just as we saw with cannabis around the world. Three, with plenty of … Continue reading “This is Why Investors are Pushing Into Psychedelics”

The Top Reasons to Consider Psychedelics

The psychedelics story has gone mainstream. For one, the US FDA is supportive of psychedelics research.  Two, medical studies from institutions such as Johns Hopkins are finding that psychedelics can assist in the treatment of many health and mental issues impacting millions of people around the world. A study in the journal, Nature — Psilocybin … Continue reading “The Top Reasons to Consider Psychedelics”